Company profile for Hansa Biopharma

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Hansa Biopharma is leveraging its proprietary enzyme technology platform to develop immunomodulatory treatments for rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection and cancer. The Company’s lead product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in highly sensitized patients and may be further developed for use in other organ and ...
Hansa Biopharma is leveraging its proprietary enzyme technology platform to develop immunomodulatory treatments for rare immunoglobulin G (IgG)-mediated autoimmune conditions, transplant rejection and cancer. The Company’s lead product candidate, imlifidase, is an antibody-cleaving enzyme being developed to enable kidney transplantation in highly sensitized patients and may be further developed for use in other organ and tissue transplantation and acute autoimmune indications. Imlifidase is currently under review for a potential marketing authorization by European Medicines Agency (EMA).

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
Sweden
Address
Address
Hansa Biopharma AB P.O. Box 785 SE-220 07 Lund
Telephone
Telephone
+46 46 16 56 70
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Default Event

PBP World Meeting

Not Confirmed

envelop Contact Supplier

PBP World Meeting

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.pharmiweb.com/press-release/2026-03-05/pdufa-action-date-for-hansa-biopharma-s-imlifidase-bla-set-for-december-19-2026

PHARMIWEB
05 Mar 2026

https://www.fiercepharma.com/pharma/fierce-pharma-regulatory-tracker-2026

FIERCE PHARMA
05 Mar 2026

https://www.pharmiweb.com/press-release/2026-02-11/hansa-biopharma-reports-fourth-quarter-and-full-year-2025-financial-results

PHARMIWEB
11 Feb 2026

https://www.pharmiweb.com/press-release/2026-01-22/hansa-biopharma-has-won-the-2025-swedenbio-award

PHARMIWEB
22 Jan 2026

https://www.prnewswire.com/news-releases/hansa-biopharma-submits-bla-to-fda-for-imlifidase-in-desensitization-for-kidney-transplantation-302647231.html

PR NEWSWIRE
20 Dec 2025

https://www.pharmiweb.com/press-release/2025-12-17/hansa-biopharma-announce-changes-to-strengthen-european-and-international-organisation

PHARMIWEB
17 Dec 2025

REF. STANDARDS & IMPURITIES

Upload your portfolio for free, ask us

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty